In all patients with CHEK2 mutation, second neoplasms developed many years after the first diagnosis: breast cancer 15 years post-nephrectomy; renal cancer 2 years post-nephrectomy; and meningioma 9 years post-nephrectomy. Here, CHEK2 is linked to renal carcinoma.